This article articulates the nuances of these court cases very well, using facts from the court hearings not CNBC reports. It seems as if PS/Valeant still have a lot of work to do and the majority of shareholders still have little interest in their offer.
With this said why are the major financial outlets covering this takeover like it's all but done and Valeant/Ackman have one? Aren't they privy to these legal facts that this author has? And if so why don't the report it? These Fabar guy on CNBC sounds like PS/Ackman's PR guy. They cover Ackman like he's Lebron James.
I'm not drinking the Koo-Aid obviously Allergan has some work to do to rid themselves of PS/Valeant but it seems as if they still hold the cards.
It's getting late. If no acquisition is made soon, it's over.
